Page last updated: 2024-11-04
suxibuzone and Gout
suxibuzone has been researched along with Gout in 1 studies
suxibuzone : A pyrazolidine that is phenylbutazone which is substituted by a 3-carboxypropanoylmethyl group at the 4-position. Suxibuzone is a prodrug for phenylbutazone and is commonly used as an anti-inflammatory drug in horses.
Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Erill, S | 1 |
| Laporte, J | 1 |
Other Studies
1 other study available for suxibuzone and Gout
| Article | Year |
|---|---|
Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
Topics: Adolescent; Adult; Drug Evaluation; Gout; Humans; Phenylbutazone; Sulfinpyrazone; Uric Acid; Uricosu | 1975 |